Latest filing published 25 Sept 2026 for NEKTAR THERAPEUTICS.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Jeffrey Robert Ajer: trading record in brief
Filings by Jeffrey Robert Ajer span 2 companies, the busiest being Biomarin Pharmaceutical Inc and Nektar Therapeutics. We count 203 filings; the first trade dates from 31 October 2012 and the latest from 23 September 2026.
Every open-market trade on record is a sale: 84 sales worth €25.2M. Outside the open market, there are 92 share grants and 27 option exercises.
Most recently, on 25 September 2026, the filings show a share grant in Nektar Therapeutics. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey Robert Ajer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares0Common StockSEC:0001193125-26-403097:0
- 5,000 shares@ US$82.911.2% of flowCommon StockSEC:0001048477-24-000073:1
- 300 shares@ US$68.6460.3% of flowCommon StockSEC:0001048477-24-000073:0
- 22,580 shares@ US$83.8726.4% of flowCommon StockSEC:0001048477-24-000036:0
- 4,000 shares@ US$87.074.9% of flowCommon StockSEC:0001048477-24-000030:0
- 9,338 shares0Common StockSEC:0001048477-24-000022:1
- 6,465 shares0Common StockSEC:0001048477-24-000022:2
- 21,440 shares0Common StockSEC:0001048477-24-000022:0
- 4,359 shares@ US$0.6917.3% of flowCommon StockSEC:0001209191-23-050220:0
- 5,000 shares@ US$90.001.2% of flowCommon StockSEC:0001048477-23-000039:1
- 318 shares@ US$66.8780.3% of flowCommon StockSEC:0001048477-23-000039:0
- 3,971 shares@ US$87.741.0% of flowCommon StockSEC:0001567619-23-005283:1
- 20,510 shares@ US$93.415.4% of flowCommon StockSEC:0001567619-23-005283:2
- 10,110 shares0Common StockSEC:0001567619-23-005283:0
- 10,380 shares0Common StockSEC:0001209191-23-014609:1
- 7,629 shares0Common StockSEC:0001209191-23-014609:2
- 20,760 shares0Common StockSEC:0001209191-23-014609:0
- 44,825 shares@ US$115.6514.3% of flowCommon StockSEC:0001567619-23-001396:1
- 4,175 shares@ US$116.151.3% of flowCommon StockSEC:0001567619-23-001396:2
- 49,000 shares@ US$67.8146.3% of flowCommon StockSEC:0001567619-23-001396:0
- 3,000 shares@ US$86.124.0% of flowCommon StockSEC:0001567619-22-019207:0
- 4,198 shares@ US$3.1682.7% of flowCommon StockSEC:0001209191-22-051304:0
- 10,200 shares0Common StockSEC:0001209191-22-050808:0
- 3,000 shares@ US$95.624.2% of flowCommon StockSEC:0001567619-22-015887:0
- 7,021 shares@ US$77.497.7% of flowCommon StockSEC:0001567619-22-012432:0
25 of 200 declarations
